Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
30 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07739654 | Modified DHAP Versus Standard DHAP in Relapsed/Refractory Diffused Large B-cell Lymphoma.(MOD-DHAP) | recruiting | Phase 3 | 74 | King Edward Medical UniversityOTHER | 1 | Aug 10, 2026 | clinicaltrials |
| NCT07323589 | Impact of Myo-Inositol Alone vs Myo-Inositol Plus Metformin on Conception, Adherence, and Tolerability in PCOS | completed | Phase 3 | 120 | PAEC general hospitalOTHER_GOV | 1 | Jan 7, 2026 |
| NCT06640530 | Clinical Study of the Efficacy and Safety of BCD-263 and Opdivo® as Monotherapy in Subjects With Advanced Melanoma of the Skin(UNIVERSE) | active not recruiting | Phase 3 | 392 | BiocadINDUSTRY | 3 | Jul 8, 2025 | clinicaltrials |
| NCT06140108 | Empagliflozin vs Metformin on Metabolic Dysfunction in Polycystic Ovary Syndrome With or Without Comorbidity or Multimorbidity | completed | Phase 2 / Phase 3 | 70 | SINA Health Education and Welfare TrustOTHER | 1 | May 14, 2025 | clinicaltrials |
| NCT00490139 | ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063D(ALTTO) | completed | Phase 3 | 8,381 | Novartis PharmaceuticalsINDUSTRY | 44 | Mar 21, 2025 | clinicaltrials |
| NCT00281658 | Study In Women And Men With Metastatic Breast Cancer That Have Overexpression Of ErbB2 | completed | Phase 3 | 444 | Novartis PharmaceuticalsINDUSTRY | 8 | Feb 10, 2023 | clinicaltrials |
| NCT05702957 | Letrozole vs Clomiphene Citrate for Induction of Ovulation in Women With Polycystic Ovarian Syndrome | completed | Phase 2 / Phase 3 | 220 | Services Institute of Medical Sciences, PakistanOTHER_GOV | 1 | Jan 27, 2023 | clinicaltrials |
| NCT05654896 | Prophylactic Antibiotic Use in Transarterial Chemoembolization for Hepatocellular Carcinoma | unknown | Phase 3 | 158 | Nadeem IqbalOTHER | 1 | Dec 16, 2022 | clinicaltrials |
| NCT05108597 | Effect of Rectal Misoprostol in Reducing Intra-operative Blood Loss During Myomectomy | completed | Phase 3 | 200 | Pak Emirates Military HospitalOTHER | 1 | Nov 5, 2021 | clinicaltrials |
| NCT00553358 | Neo ALTTO (Neoadjuvant Lapatinib and/or Trastuzumab Treatment Optimisation) Study(Neo ALTTO) | completed | Phase 3 | 455 | Novartis PharmaceuticalsINDUSTRY | 24 | Sep 21, 2021 | clinicaltrials |
| NCT01566721 | A Safety and Tolerability Study of Assisted and Self-Administered Subcutaneous (SC) Herceptin (Trastuzumab) as Adjuvant Therapy in Early Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer(SafeHER) | completed | Phase 3 | 2,577 | Hoffmann-La RocheINDUSTRY | 59 | Apr 27, 2021 | clinicaltrials |
| NCT00073528 | Study Comparing Lapatinib (GW572016) And Letrozole Versus Letrozole In Subjects With Advanced Or Metastatic Breast Cancer | completed | Phase 3 | 1,286 | Novartis PharmaceuticalsINDUSTRY | 29 | Feb 24, 2021 | clinicaltrials |
| NCT01572038 | A Study of Pertuzumab in Combination With Trastuzumab (Herceptin) and a Taxane in First-Line Treatment in Participants With Human Epidermal Growth Factor 2 (HER2)-Positive Advanced Breast Cancer(PERUSE) | completed | Phase 3 | 1,436 | Hoffmann-La RocheINDUSTRY | 39 | Sep 25, 2020 | clinicaltrials |
| NCT03824925 | Efficacy of Zinc on Concurrent Chemo-radiotherapy Induced Taste Alterations | completed | Phase 3 | 70 | Dow University of Health SciencesOTHER | 1 | Jan 31, 2019 | clinicaltrials |
| NCT01767467 | Study to Assess the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine in Adults Aged 18 Years and Older With Blood Cancers | completed | Phase 3 | 568 | GlaxoSmithKlineINDUSTRY | 21 | Jun 6, 2018 | clinicaltrials |
| NCT00431236 | A Study of the Drug Casopitant for the Prevention of Nausea Caused By Cisplatin-Based Highly Emetogenic Chemotherapy | completed | Phase 3 | 810 | GlaxoSmithKlineINDUSTRY | 22 | Aug 22, 2017 | clinicaltrials |
| NCT00428090 | Rosiglitazone (Extended Release Tablets) As Monotherapy In Subjects With Mild To Moderate Alzheimer's Disease | completed | Phase 3 | 862 | GlaxoSmithKlineINDUSTRY | 20 | May 19, 2017 | clinicaltrials |
| NCT01507467 | IAEA-HypoX. Accelerated Radiotherapy With or Without Nimorazole in Squamous Cell Carcinoma of the Head and Neck(IAEA-HypoX) | terminated | Phase 3 | 104 | Danish Head and Neck Cancer GroupNETWORK | 4 | Nov 25, 2016 | clinicaltrials |
| NCT00334282 | Safety and Efficacy of GW786034 (Pazopanib) In Metastatic Renal Cell Carcinoma | completed | Phase 3 | 435 | GlaxoSmithKlineINDUSTRY | 25 | Feb 5, 2016 | clinicaltrials |
| NCT00075270 | Paclitaxel With / Without GW572016 (Lapatinib) As First Line Therapy For Women With Advanced Or Metastatic Breast Cancer | completed | Phase 3 | 580 | GlaxoSmithKlineINDUSTRY | 25 | May 6, 2015 | clinicaltrials |
| NCT00863746 | A 3rd/4th Line Placebo-controlled Trial of Sorafenib in Patients With Predominantly Non Squamous Non-Small Cell Lung Cancer (NSCLC).(MISSION) | completed | Phase 3 | 703 | BayerINDUSTRY | 34 | Jan 19, 2015 | clinicaltrials |
| NCT00387764 | Extension Study to VEG105192 to Assess Pazopanib in Patients With Advanced/Metastatic Renal Cell Cancer | completed | Phase 3 | 80 | GlaxoSmithKlineINDUSTRY | 20 | Jan 14, 2014 | clinicaltrials |
| NCT00864331 | Optimization of Treatment of Advanced Nonsmall Cell Lung Cancer Using Radiotherapy and Chemotherapy | completed | Phase 3 | 251 | International Atomic Energy AgencyOTHER_GOV | 13 | Aug 7, 2013 | clinicaltrials |
| NCT00003424 | Tamoxifen in Treating Patients With Primary Liver Cancer | completed | Phase 3 | 300 | National Medical Research Council (NMRC), SingaporeOTHER_GOV | 6 | Jun 26, 2013 | clinicaltrials |
| NCT01587248 | Use of Harmonic in Breast Surgery(HMRM) | completed | Phase 3 | 152 | Aga Khan UniversityOTHER | 1 | Apr 30, 2012 | clinicaltrials |
| NCT01452672 | Resource-sparing Post-mastectomy Radiotherapy in Breast Cancer | unknown | Phase 3 | 600 | International Atomic Energy AgencyOTHER_GOV | 8 | Oct 17, 2011 | clinicaltrials |
| NCT00122772 | CRP on Radiobiological and Clinical Studies on Viral-Induced Cancer's Response to Radiotherapy | completed | Phase 3 | 601 | International Atomic Energy AgencyOTHER_GOV | 11 | Oct 14, 2011 | clinicaltrials |
| NCT00665197 | Palliative Radiotherapy and Brachytherapy for Oesophageal Cancer Dysphagia | completed | Phase 3 | 200 | International Atomic Energy AgencyOTHER_GOV | 7 | Oct 13, 2011 | clinicaltrials |
| NCT00035425 | Treatment of Neutropenic Patients With Fever Who Are Suspected to Have A Gram Positive Infection | completed | Phase 3 | 120 | PfizerINDUSTRY | 10 | Dec 1, 2009 | clinicaltrials |
| NCT00191100 | Comparative Study of Gemcitabine,Cisplatin and Radiation Versus Cisplatin and Radiation in Cancer of the Cervix | completed | Phase 3 | 515 | Eli Lilly and CompanyINDUSTRY | 7 | Aug 11, 2009 | clinicaltrials |
Data updated 22 days agoSource updated unknownsource: clinicaltrials